J Gynecol Oncol.  2015 Oct;26(4):270-276. 10.3802/jgo.2015.26.4.270.

Pulmonary metastasectomy in uterine malignancy: outcomes and prognostic factors

• Paik ES
• Yoon A
• Lee YY
• Kim TJ
• Lee JW
• Bae DS
• Kim BG

• KMID: 2345917
• DOI: http://doi.org/10.3802/jgo.2015.26.4.270

Abstract

OBJECTIVE
The aim of this study was to investigate outcomes in uterine cancer patients undergoing pulmonary metastasectomy and prognostic factors associated with survival after the procedure.
METHODS
A retrospective study was performed in 29 uterine cancer patients who underwent surgical resection of pulmonary metastatic lesions at Samsung Medical Center between June 1995 and December 2011.
RESULTS
Histopathology showed carcinoma in 17 patients (58.6%) and sarcoma in 12 patients (41.4%). Of the 29 patients, 17 (58.6%) had less than three pulmonary metastatic lesions. Eight (27.6%) had symptoms related to lung metastasis. The 5-year survival rate after pulmonary metastasectomy for the entire cohort was 48.2%. On univariate and multivariate analysis, the presence of pulmonary symptoms and more than three lesions of metastasis were associated with poor survival after pulmonary metastasectomy.
CONCLUSION
Pulmonary metastasectomy for uterine cancer is an acceptable treatment in selected patients. Patients with more than three pulmonary metastatic lesions and pulmonary symptoms related to lung metastasis could expect to have worse prognosis after pulmonary metastasectomy.

Keyword

Metastasectomy; Prognosis; Retrospective Studies; Survival Rate; Uterine Neoplasms

MeSH Terms

Adenocarcinoma/secondary/surgery
Adult
Aged
Combined Modality Therapy
Female
Humans
Hysterectomy/methods
Leiomyosarcoma/*secondary/*surgery
Lung Neoplasms/*secondary/*surgery
Metastasectomy/*methods
Middle Aged
Prognosis
Retrospective Studies
Treatment Outcome
*Uterine Neoplasms

Figure

• 

  Fig. 1 Kaplan-Meier curves for survival from metastasectomy based on the symptoms related to lung metastasis.

• 

  Fig. 2 Kaplan-Meier curves for survival from metastasectomy according to the number of pulmonary lesions.

Reference

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014; 64:9–29.

2. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer. 1987; 60:8 Suppl. 2035–2041.

3. Ballon SC, Berman ML, Donaldson RC, Growdon WA, Lagasse LD. Pulmonary metastases of endometrial carcinoma. Gynecol Oncol. 1979; 7:56–65.

4. Bouros D, Papadakis K, Siafakas N, Fuller AF Jr. Patterns of pulmonary metastasis from uterine cancer. Oncology. 1996; 53:360–363.

5. Downey RJ. Surgical treatment of pulmonary metastases. Surg Oncol Clin N Am. 1999; 8:341.

6. Dabestani S, Marconi L, Hofmann F, Stewart F, Lam TB, Canfield SE, et al. Local treatments for metastases of renal cell carcinoma: a systematic review. Lancet Oncol. 2014; 15:e549–e561.

7. Pfannschmidt J, Dienemann H, Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Ann Thorac Surg. 2007; 84:324–338.

8. Tomimaru Y, Sasaki Y, Yamada T, Eguchi H, Takami K, Ohigashi H, et al. The significance of surgical resection for pulmonary metastasis from hepatocellular carcinoma. Am J Surg. 2006; 192:46–51.

9. Friedel G, Pastorino U, Ginsberg RJ, Goldstraw P, Johnston M, Pass H, et al. Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the International Registry of Lung Metastases. Eur J Cardiothorac Surg. 2002; 22:335–344.

10. Yano T, Shoji F, Maehara Y. Current status of pulmonary metastasectomy from primary epithelial tumors. Surg Today. 2009; 39:91–97.

11. Miyazaki T, Hasegawa Y, Hanai N, Ozawa T, Hirakawa H, Suzuki A, et al. Survival impact of pulmonary metastasectomy for patients with head and neck cancer. Head Neck. 2013; 35:1745–1751.

12. Torek F. Removal of metastatic carcinoma of the lung and mediastinum: suggestions as to technic. Arch Surg. 1930; 21:1416–1424.

13. Clavero JM, Deschamps C, Cassivi SD, Allen MS, Nichols FC 3rd, Barrette BA, et al. Gynecologic cancers: factors affecting survival after pulmonary metastasectomy. Ann Thorac Surg. 2006; 81:2004–2007.

14. Yamamoto K, Yoshikawa H, Shiromizu K, Saito T, Kuzuya K, Tsunematsu R, et al. Pulmonary metastasectomy for uterine cervical cancer: a multivariate analysis. Ann Thorac Surg. 2004; 77:1179–1182.

15. Fuller AF Jr, Scannell JG, Wilkins EW Jr. Pulmonary resection for metastases from gynecologic cancers: Massachusetts General Hospital experience, 1943-1982. Gynecol Oncol. 1985; 22:174–180.

16. Levenback C, Rubin SC, McCormack PM, Hoskins WJ, Atkinson EN, Lewis JL Jr. Resection of pulmonary metastases from uterine sarcomas. Gynecol Oncol. 1992; 45:202–205.

17. Shiromizu K, Kasamatsu T, Takahashi M, Kikuchi A, Yoshinari T, Matsuzawa M. A clinicopathological study of postoperative pulmonary metastasis of uterine cervical carcinomas. J Obstet Gynaecol Res. 1999; 25:245–249.

18. Ayhan A, Taskiran C, Celik C, Yuce K, Kucukali T. The influence of cytoreductive surgery on survival and morbidity in stage IVB endometrial cancer. Int J Gynecol Cancer. 2002; 12:448–453.

19. Ueda Y, Enomoto T, Miyatake T, Egawa-Takata T, Ugaki H, Yoshino K, et al. Endometrial carcinoma with extra-abdominal metastasis: improved prognosis following cytoreductive surgery. Ann Surg Oncol. 2010; 17:1111–1117.

20. Eto T, Saito T, Kasamatsu T, Nakanishi T, Yokota H, Satoh T, et al. Clinicopathological prognostic factors and the role of cytoreduction in surgical stage IVb endometrial cancer: a retrospective multi-institutional analysis of 248 patients in Japan. Gynecol Oncol. 2012; 127:338–344.

21. Dowdy SC, Mariani A, Bakkum JN, Cliby WA, Keeney GL, Podratz KC. Treatment of pulmonary recurrences in patients with endometrial cancer. Gynecol Oncol. 2007; 107:242–247.

22. Otsuka I, Ono I, Akamatsu H, Sunamori M, Aso T. Pulmonary metastasis from endometrial carcinoma. Int J Gynecol Cancer. 2002; 12:208–213.

23. Creasman WT, Odicino F, Maisonneuve P, Quinn MA, Beller U, Benedet JL, et al. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006; 95:Suppl 1. S105–S143.

24. Anraku M, Yokoi K, Nakagawa K, Fujisawa T, Nakajima J, Akiyama H, et al. Pulmonary metastases from uterine malignancies: results of surgical resection in 133 patients. J Thorac Cardiovasc Surg. 2004; 127:1107–1112.

25. Todd TR. The surgical treatment of pulmonary metastases. Chest. 1997; 112:4 Suppl. 287S–290S.

26. Takita H, Edgerton F, Karakousis C, Douglass HO Jr, Vincent RG, Beckley S. Surgical management of metastases to the lung. Surg Gynecol Obstet. 1981; 152:191–194.

27. Zink S, Kayser G, Gabius HJ, Kayser K. Survival, disease-free interval, and associated tumor features in patients with colon/rectal carcinomas and their resected intra-pulmonary metastases. Eur J Cardiothorac Surg. 2001; 19:908–913.

28. Girard P, Spaggiari L, Baldeyrou P, Le Chevalier T, Le Cesne A, Escudier B, et al. Should the number of pulmonary metastases influence the surgical decision. Eur J Cardiothorac Surg. 1997; 12:385–391.